TrialArthritis research & therapy2021

Therapeutic potential of targeting Tfr/Tfh cell balance by low-dose-IL-2 in active SLE: a post hoc analysis from a double-blind RCT study.

Miao Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.